6 quiz questions available for this topicTake Quiz

Halitosis

786 wordsUpdated 03/03/2026
💡

Exam Tips

  • In OSCEs, separate mouth and nose organoleptic testing to localize source (oral vs nasal/sinus vs rare systemic).
  • Most persistent objective halitosis is intra-oral (about 85-90%): think tongue dorsum biofilm and periodontal pockets first.
  • A normal objective exam on repeated visits with persistent concern suggests pseudo-halitosis/halitophobia; avoid unnecessary invasive investigations.
  • Always screen for red flags (weight loss, unilateral persistent ENT symptoms, neck mass, haemoptysis, progressive dysphagia).
  • State safety points in viva answers: chlorhexidine staining/taste disturbance, miconazole-warfarin interaction, metronidazole-alcohol and warfarin interaction.
  • Visual learning cue: revise a diagram of posterior tongue biofilm and periodontal pocket anatomy (see figure in your oral pathology textbook chapter on halitosis mechanisms).

Definition

Halitosis is an unpleasant odour detected on exhaled breath and may be physiological (for example morning breath), pathological, or subjective. In persistent objective halitosis, the source is most often intra-oral (such as tongue coating or periodontal disease), while extra-oral and psychogenic causes are less common but clinically important.

Pathophysiology

Most persistent halitosis is driven by oral biofilm metabolism, especially Gram-negative anaerobes on the posterior dorsal tongue and in periodontal pockets. These bacteria degrade sulphur-containing amino acids from food debris, saliva, blood, and desquamated cells, releasing volatile sulphur compounds (hydrogen sulphide, methyl mercaptan) plus polyamines, indoles, and short-chain fatty acids that create malodour. Reduced salivary flow (sleep, fasting, xerostomia, smoking, alcohol, anticholinergic medicines) worsens this by reducing mechanical cleansing and buffering. Extra-oral halitosis arises when odorous compounds are generated in ENT/respiratory/GI disease or in systemic metabolic states and then exhaled via the lungs.

Risk Factors

  • Poor oral hygiene with tongue coating and plaque accumulation
  • Gingivitis or periodontitis
  • Xerostomia (including medication-related dry mouth, Sjogren syndrome, radiotherapy/chemotherapy)
  • Smoking and regular alcohol intake
  • Dentures or orthodontic appliances with poor cleaning/night-time wear
  • Frequent intake of odiferous foods (for example garlic, onion, spices)
  • ENT disease (sinusitis, tonsillitis, tonsilloliths, postnasal drip, nasal obstruction)
  • Respiratory disease (bronchiectasis, lung abscess, lung malignancy)
  • Upper GI pathology (GORD, oesophageal diverticulum, gastric/upper GI malignancy)
  • Psychological vulnerability to pseudo-halitosis/halitophobia

Clinical Features

Symptoms

  • Self-reported bad breath, often worse on waking or during fasting
  • Dry mouth, reduced taste, or difficulty swallowing
  • Bleeding gums, gum soreness, loose teeth, or oral pain
  • Nasal blockage/discharge, postnasal drip, sore throat, cough
  • Social avoidance, embarrassment, anxiety, low mood
  • Behavioural changes (covering mouth, avoiding close contact)

Signs

  • Objective malodour on organoleptic assessment
  • Tongue coating, especially posterior dorsum
  • Plaque, dental caries, gingival inflammation, periodontal pockets
  • Poorly fitting prosthesis or unclean dentures
  • Features of oral infection (for example candidiasis, dental abscess, ulceration)
  • Red flags for head and neck/upper GI/lung cancer (weight loss, persistent unilateral symptoms, neck mass)

Investigations

Focused history and oral examination:Identifies likely oral source (tongue coating, periodontal disease, caries, prosthesis hygiene issues) and contributing lifestyle factors
Organoleptic breath assessment (mouth and nose separately):Mouth only suggests oral/pharyngeal source; nose only suggests nasal/sinus source; both similarly suggests systemic origin (rare)
Repeat objective assessment on 2-3 occasions if initial test negative:Persistent lack of objective malodour supports pseudo-halitosis or halitophobia
Dental assessment (GDP/dental hygienist, periodontal charting as needed):Confirms gingivitis/periodontitis, caries, faulty restorations, denture-related disease
Targeted tests for suspected extra-oral disease:ENT, respiratory, GI, or metabolic investigations guided by symptoms/red flags rather than routine blanket testing

Management

Lifestyle Modifications

  • Explain cause and classify as physiological, pathological, or subjective; give reassurance where appropriate
  • Optimize oral hygiene: brush teeth twice daily with fluoride toothpaste, clean interdentally, and clean posterior tongue daily
  • Hydration and saliva support (regular water; sugar-free/xylitol gum if appropriate)
  • Stop smoking, reduce alcohol, and limit recurrent trigger foods
  • Improve denture care: clean daily, remove at night, review fit
  • Address psychosocial impact; if no objective halitosis, provide structured reassurance and consider mental health support for halitophobia

Pharmacological Treatment

Antiseptic mouthrinse (adjunct, short course)

  • Chlorhexidine gluconate 0.2% mouthwash, 10 mL for 1 minute twice daily
  • Hydrogen peroxide 6% mouthwash concentrate, dilute and rinse 2-3 times daily (short-term use)

Use as an adjunct to mechanical cleaning, not a substitute. Chlorhexidine may cause tooth/tongue staining, taste disturbance, and increased calculus with prolonged use; avoid long continuous courses.

Management of oral candidiasis when present

  • Miconazole oral gel 20 mg/g, 2.5 mL four times daily after food
  • Nystatin oral suspension 100,000 units/mL, 1 mL four times daily

Continue at least 7 days after lesion resolution. Important safety: miconazole markedly increases INR with warfarin (avoid/seek specialist advice).

Antibiotics for confirmed odontogenic infection with systemic spread/risk

  • Amoxicillin 500 mg three times daily for 5 days
  • Metronidazole 400 mg three times daily for 5 days (penicillin allergy or anaerobic predominance)

Use only when clear indication exists; definitive dental source control is essential. Safety: metronidazole interacts with alcohol (disulfiram-like reaction) and warfarin (raised INR).

Surgical / Interventional

  • Definitive dental procedures when indicated (scaling/root planing, caries treatment, drainage or extraction for dental abscess)
  • ENT procedures for selected causes (for example tonsillolith management, foreign body removal, drainage of deep neck/nasopharyngeal abscess)
  • Urgent specialist pathway for suspected oral, head and neck, lung, or upper GI malignancy

Complications

  • Reduced quality of life and social functioning
  • Low self-esteem, stigma, relationship and occupational difficulties
  • Anxiety and depressive symptoms
  • Compulsive oral-cleansing behaviours in halitophobia
  • Delayed diagnosis if serious extra-oral cause is missed

Prognosis

Prognosis is usually good when the underlying cause is identified and treated, particularly for intra-oral disease with sustained hygiene measures. Physiological halitosis is typically transient. Persistent symptoms without objective malodour may follow a chronic psychological course and benefit from combined dental, medical, and mental health input.

Sources & References

Test Your Knowledge

6 quiz questions available for this topic

Start Quiz